Status:
COMPLETED
Paracervical Block Before Intrauterine Device (IUD) Insertion
Lead Sponsor:
Northwestern University
Conditions:
Pain Control for Intrauterine Device Insertions
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate if a paracervical block containing 1% lidocaine administered prior to IUD insertion reduces insertion pain. The hypothesis is that women receiving paracervical...
Eligibility Criteria
Inclusion
- Women age 18 -50 years
- A negative urine pregnancy test and clinically unlikely to be pregnant
- Seeking an intrauterine device for any indication
- Willing and able to sign an informed consent in English
Exclusion
- History of a prior IUD successful insertion
- Previous failed insertion of an IUD
- Known copper allergy
- Known levonorgestrel allergy
- Known lidocaine allergy
- Current cervicitis
- Pelvic Inflammatory Disease (PID) within 3 months
- Pregnancy within six weeks prior to IUD insertion
- Uterine anomaly or distortion of the uterine cavity
- Use of any other pain medication within 6 hours prior to IUD insertion
- Use of misoprostol within 24 hours prior to IUD insertion
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01207401
Start Date
July 1 2010
End Date
February 1 2011
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medical Faculty Foundation or Prentice Ambulatory Care Clinic
Chicago, Illinois, United States, 60611